TABLE 6.
Geometric means and 95% confidence intervals for the expression of each gene by clinical categorya
Gene | C (n = 386) |
TT (n = 142) |
TTI (n = 244) |
TTI vs C |
TT vs C |
TTI vs TT |
Pd | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | FC | Pb | FC | Pb | FC | Pc | ||
IFNγ | 0.0212 | 0.0191-0.0235 | 0.0194 | 0.0167-0.0225 | 0.0178 | 0.0157-0.0203 | 0.78 | 0.0433 | 1.03 | 0.8282 | 0.92 | 0.4293 | 0.1105 |
TNFα | 0.2064 | 0.1964-0.2169 | 0.2261 | 0.2013-0.2539 | 0.2370 | 0.2150-0.2613 | 1.11 | 0.0767 | 1.16 | 0.0403 | 1.05 | 0.5474 | 0.0236 |
IL1B | 0.6248 | 0.5763-0.6775 | 1.1038 | 0.9131-1.3343 | 1.4000 | 1.2127-1.6164 | 2.18 | <0.0001 | 1.86 | <0.0001 | 1.27 | 0.0489 | <0.0001 |
IL10 | 0.0361 | 0.0321-0.0407 | 0.0429 | 0.0346-0.0532 | 0.0418 | 0.0358-0.0487 | 1.08 | 0.4941 | 1.34 | 0.0660 | 0.97 | 0.8449 | 0.2055 |
IL13 | 0.0018 | 0.0016-0.0022 | 0.0012 | 0.0007-0.0015 | 0.0009 | 0.0007-0.0011 | 0.45 | 0.0002 | 0.72 | 0.0545 | 0.75 | 0.3895 | <0.0001 |
IL13RA2 | 0.0083 | 0.0075-0.0093 | 0.0184 | 0.0153-0.0223 | 0.0178 | 0.0149-0.0214 | 2.17 | <0.0001 | 2.12 | <0.0001 | 0.97 | 0.7785 | <0.0001 |
IL19e | 0.00003 | 0.00002-0.00004 | 0.0001 | 0.00007-0.00014 | 0.0001 | 0.00009-0.00016 | 2.98 | 0.0001 | 3.10 | 0.0227 | 1.29 | 0.2400 | <0.0001 |
ARG1 | 0.0331 | 0.0310-0.0353 | 0.0408 | 0.0349-0.0476 | 0.0432 | 0.0383-0.0489 | 1.30 | 0.0007 | 1.24 | 0.0109 | 1.06 | 0.5599 | 0.0001 |
NOS2A | 0.7908 | 0.7247-0.8629 | 2.0494 | 1.7665-2.3776 | 2.4573 | 2.1770-2.7737 | 3.28 | <0.0001 | 2.36 | <0.0001 | 1.20 | 0.0671 | <0.0001 |
INDO | 1.0955 | 0.9907-1.2113 | 3.4223 | 2.9046-4.0323 | 4.3953 | 3.8411-5.0295 | 4.10 | <0.0001 | 3.02 | <0.0001 | 1.28 | 0.0232 | <0.0001 |
CXCL5 | 0.0070 | 0.0058-0.0084 | 0.0248 | 0.0178-0.0344 | 0.0419 | 0.0323-0.0543 | 6.39 | <0.0001 | 3.15 | <0.0001 | 1.69 | 0.0145 | <0.0001 |
S100A7 | 0.3972 | 0.3568-0.4421 | 3.4075 | 2.4726-4.6959 | 5.8468 | 4.5231-7.5579 | 14.61 | <0.0001 | 8.69 | <0.0001 | 1.72 | 0.0109 | <0.0001 |
MMP7 | 1.0005 | 0.9169-1.0917 | 2.7078 | 2.2781-3.2186 | 3.1925 | 2.8415-3.5868 | 3.14 | <0.0001 | 2.79 | <0.0001 | 1.18 | 0.1079 | <0.0001 |
MMP9 | 0.0340 | 0.0305-0.0378 | 0.0570 | 0.0478-0.0679 | 0.0633 | 0.0554-0.0723 | 1.88 | <0.0001 | 1.65 | 0.0001 | 1.11 | 0.3429 | <0.0001 |
MMP12 | 0.4047 | 0.3662-0.4473 | 0.7397 | 0.6247-0.8759 | 0.8437 | 0.7329-0.9714 | 2.08 | <0.0001 | 1.84 | <0.0001 | 1.14 | 0.2501 | <0.0001 |
HAS3 | 0.1456 | 0.1313-0.1613 | 0.2232 | 0.1904-0.2619 | 0.2441 | 0.2133-0.2793 | 1.68 | <0.0001 | 1.53 | 0.0001 | 1.09 | 0.4136 | <0.0001 |
IL13/IL13RA2f | 0.1911 | 0.1556-0.2348 | 0.0505 | 0.0340-0.0750 | 0.0425 | 0.0330-0.0547 | 0.20 | <0.0001 | 0.28 | 0.0001 | 0.84 | 0.4435 | <0.0001 |
The expression levels are standardized relative to the expression of HPRT1 in the same reaction. FC, fold change (a value of >1 indicates increased expression in the first clinical category of each comparison compared to the second).
P values for paired t test. Using the Bonferroni correction, the critical significance threshold level is a P value of <0.001.
P values for unpaired t test. Using the Bonferroni correction, the critical significance threshold level is a P value of <0.001.
As determined by analysis of variance of the expression level of the gene across the three clinical categories.
For IL19, only cases or controls where expression was detected are included.
That is, the ratio of IL13/IL13RA expression.